
- •Ticket 1
- •3. Antihypertensive agents affecting water-salt exchange. Classification. Mechanism of action. Side effects. Contraindications. Comparative evaluation of preparations.
- •4. Antiseptics of aromatic and aliphatic series. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 2.
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2. Binding, engraving, adsorbating, irritating substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •3. Drugs stimulating fibrinolysis. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative assessment.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 3.
- •1. Suction of medicinal substances from the place of administration. Transportation of medicinal substances through cellular membranes.
- •2.Tranquilizers. Classification. Action mechanism. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1) Means used for diagnostic purposes
- •Indications: used in case of weakened but preserved gastric function
- •2. Antiseptics - compounds of metals. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 4
- •Gink derivatives
- •Indications for use:
- •I Inhibition of the activity of the thromboxane system
- •III Drugs that inhibit the binding of fibrinogen to platelet glycoprotein receptors
- •Season 5
- •Indications:
- •Season 6
- •Indications:
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket 7
- •1. Development of pharmacology in Russia. Pharmokopeia, its legal significance. Prescription - Jur. Document.
- •2. Counterarkinsonian funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Rational combination and combined drugs for the treatment of hypertension. Explain the rationality of the application.
- •Ticket 8
- •3. Anticoagulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 9
- •3. Drugs used to treat bronchial asthma. Classification. Mechanisms of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 10
- •1. Definition of pharmacology as a science, its tasks, place among other medical and biological sciences. Scientific substantiation of the need for animal experiments.
- •Ticket 11
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia
- •3. Cardiac glycosides. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •I. Means used in the treatment of diseases caused by pathogenic fungi:
- •II. Drugs used in the treatment of diseases caused by opportunistic fungi (for example, with candidiasis):
- •Ticket number 12
- •Types of action of medicinal substances
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 13
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •3. Preparations of sex hormones and their antagonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Indications for use:
- •4. Antimalarial drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 14
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3. Preparations of fat-soluble vitamins. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Vitamin a preparations are indicated:
- •Ticket 15
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3. Antihypertensive drugs of peripheral neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 16
- •1. Types of action of medicinal substances.
- •2. Sympatholytic remedies. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Spectrum of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 17.
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Analeptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Choleretic drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 18.
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Antacids. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative characteristics.
- •Ticket 19
- •1. The combined effect of drugs. Synergy. Antagonism. Antidote.
- •2.Sleeping drugs. Classification by chemical structure. Mechanism of action. Side effects. Contraindications Comparative evaluation. Possibilities for the development of addiction.
- •3. Class II antiarrhythmic drugs (Beta-blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 20
- •1. Changes in the body's reactions to medicinal substances during their repeated administration. The concept of addiction, drug dependence, tachyphylaxis, sensitization. Cumulation of drugs.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of the drug.
- •3. Means that reduce the secretion of gastric glands. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •Ticket 21
- •1. Basic principles of first aid for acute drug poisoning.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3.Calcium channel blockers for the treatment of coronary heart disease. Classification Mechanism of action Side effects Contraindications Comparative assessment of drugs
- •Ticket number 22
- •3). Leukopoiesis stimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 23
- •2). Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •1. Plant origin
- •2. Synthetic morphine substitutes
- •3). Gastroprotectors. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket number 24
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3). Diuretics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Ticket 25
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •3. Antitussives. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 26
- •2. Sedatives. Classification. Mechanism of action. Indications for use Side effects Contraindications Comparative evaluation of drugs.
- •3. Anti-inflammatory drugs of steroid structure. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 27
- •1. Basic principles and methods of testing new medicinal substances. The concepts of "placebo" and "blind" control. The ethical side of prescribing a placebo.
- •3. Means that help stop bleeding (hemostatics). Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket number 28
- •1. Combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Psychostimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 29
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Drugs affecting immunity. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 30
- •2. Sympatholytic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Preparations of pancreatic hormones. Synthetic hypoglycemic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 31
- •1. Distribution of medicinal substances in the body. Biotransformation of medicinal substances in the body and ways of their excretion. Concept and bioavailability.
- •2. Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •3. Laxatives. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 32.
- •3. Stimulants of respiration. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 33.
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia.
- •3. Class IV antiarrhythmics (calcium channel blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 34
- •1) Development of pharmacology in Russia. Pharmacology and its legal significance. Treating the recipe as a legal document.
- •3... Antihypertensive drugs that affect the renin-angiotensin system. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Indications for use. Side effects. Contraindications Comparative characteristics of drugs.
- •Ticket 35
- •6. Homeopathy, basic principles. Evaluation of the homeopathic treatment method.
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3) Drugs used in myocardial infarction. Classification. Mechanism of action. Side effects. Contraindications Indications for use. Comparative characteristics
- •Ticket 36
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3) Anti-atherosclerotic drugs. Classification, Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation.
- •Indications:
- •Ticket 37
- •Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •1. Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •3. Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 38
- •4. Antiblastic substances. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 39
- •4. Differences between chemotherapeutic agents and antiseptics. Basic principles of ht. Criteria for evaluation.
- •Ticket 40.
- •3. Preparations of water-soluble vitamins. Classification. Mechanism of action. Indications. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antihelminthic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 41.
- •1. Principles of drug discovery. Ways of synthesis of pharmacological substances. Obtaining preparations from plant and animal raw materials.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Class III antiarrhythmic drugs (potassium channel blockers). Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •4. Dyes. Detergents. Oxidizing agents. Acids and alkalis.
- •Ticket 42
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov).
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Vomiting and antiemetic. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 43
- •1. The combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Antiparkinsonian drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Enzyme preparations. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 44.
- •The dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Curariform funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Means that affect appetite. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •1.Media that stimulate appetite:
- •Ticket 45.
- •1. Types of action of medicinal substances.
- •2. Antidepressants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Gink derivatives
- •Indications for use:
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 46
- •Ticket 47
- •3. Means that increase the tone and contraction of the myometrium. Classification. Mechanism of action. Indications for use. Contraindications Comparative evaluation of drugs.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 48
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3. Antiadrenergic drugs for the treatment of coronary heart disease. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiseptics - metal compounds. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Blockers of calcium channels for the treatment of hypertension. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 50
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of the drug.
- •3. Preparations of pituitary hormones. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use
- •Indications for use
- •Indications for use:
- •Ticket 51
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Glycosidic intoxication. Preventive and emergency measures.
- •Ticket 52
- •3. Antihypertensive drugs of myotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
3. Cardiac glycosides. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
Cardiac glycosides - complex nitrogen-free substances of plant origin with a pronounced cardiotonic effect.
CLASSIFICATION
Short-acting drugs with a short latency period and low cumulative potential: Korglikon (Landysh), Strofantin (Strofant) - in / in
|
Korglikon |
Strofantin |
The beginning of the development of the effect |
3-5 minutes |
5-10 minutes |
Maximum effect |
20-30 minutes |
30-60 minutes |
Full termination |
4-6 h |
1-3 days |
Chemical structure |
Highly polar |
Medium duration drugs with an average latency period and an average cumulative capacity: DIGOXIN, CELLANIDE (intravenous, inside). ADONISIDE, HORIZONTAL HERBAL NATURAL, CARDIOVALENE - inside
All drugs in this group are characterized by: The beginning of the development of the effect - 30 min - 2 h
Maximum effect - 6-8 hours
Complete cessation of action - 2-7 days
By chemical structure - medium polarity
Long-acting drugs with a pronounced latency period and the ability to cumulate: DIGITOXIN, CORDIGIT
Preparations for oral administration only
Well absorbed from the gastrointestinal tract (low polarity, lipophilic)
The beginning of the development of the effect - 2-4 hours
Maximum effect - 12 hours
Complete cessation of action - 2-3 weeks
EFFECTS OF GLYCOSIDES:
- chronotron negative (AV-conductivity decreases)
- negative dromotropic (slows down the repolarization phase and increases the refractory period)
- put batmotropic - increase the efficiency of the myocardium
- increases automatism
- reduction of edema, shortness of breath
- decrease in venous pressure and BCC
- increased urine output
Cardiac glycosides differ in the duration of the latent period of action and the rate of increase in the effect. When administered intravenously, STROFANTIN begins to act in 5-10 minutes, and CELANID in 5-30. With the introduction of DIGOXIN, the effect develops after 30 minutes, and with the administration of DIGITOXIN after 2 hours
With intravenous administration, the maximum effect occurs especially quickly with STROFANTIN (30 min), then DIGOXIN AND CELLANIDE (1-5H), then DIGITOXIN (4-12H),
INDICATIONS: - acute and chronic heart failure - supraventricular arrhythmias |
KIDNEY: -decrease in heart rate less than 50 - AV blockade - nausea, vomiting - drowsiness, lethargy - irritation of the gastrointestinal tract - xanthopsia - a change in color perception (green tones prevail) |
CONTRAINDICATIONS: -AV block - bradycardia - hypokalemia - acute infectious myocarditis |